Get started
Neuland Laboratories Ltd.Neuland Laboratories Ltd.Neuland Laboratories Ltd.

Neuland Laboratories Ltd.

No trades
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsETFs

Trade ideas

SWING IDEA - NEULAND LABNeuland Lab , a niche API manufacturer with strong export presence and leadership in complex molecules, is offering a technically strong swing trade opportunity from key support levels. Reasons are listed below : 11,500 zone acting as a crucial support area Formation of a hammer candle on the weekly timeframe, signaling potential reversal Reversing from the 0.618 Fibonacci retracement zone – the golden pocket Taking support at the 50-week EMA , holding long-term trend structure Target - 14900 // 17600 Stoploss - weekly close below 10215 DISCLAIMER - Decisions to buy, sell, hold or trade in securities, commodities and other investments involve risk and are best made based on the advice of qualified financial professionals. Any trading in securities or other investments involves a risk of substantial losses. The practice of "Day Trading" involves particularly high risks and can cause you to lose substantial sums of money. Before undertaking any trading program, you should consult a qualified financial professional. Please consider carefully whether such trading is suitable for you in light of your financial condition and ability to bear financial risks. Under no circumstances shall we be liable for any loss or damage you or anyone else incurs as a result of any trading or investment activity that you or anyone else engages in based on any information or material you receive through TradingView or our services. @visionary.growth.insights
NSE:NEULANDLABLong
by Visionary_Growth_Insights
Neuland LabsNeuland Labs (currently trading at ₹16098) is a Hyderabad-based pharmaceutical company specializing in complex APIs for global innovators and generic players. With over 70% of revenue from exports, Neuland is a trusted supplier to top-10 global pharma firms and has deep expertise in niche segments like CNS, respiratory, and peptide APIs. It operates two USFDA-approved manufacturing facilities and a dedicated R&D center, with a strong focus on backward integration, process chemistry, and lifecycle management. Neuland Labs – FY22–FY25 Snapshot • Sales – ₹1,020 Cr → ₹1,280 Cr → ₹1,520 Cr → ₹1,750 Cr Growth driven by CMS (Custom Manufacturing Services) and peptide APIs • Net Profit – ₹85 Cr → ₹120 Cr → ₹160 Cr → ₹190 Cr Earnings supported by margin expansion and high-value molecules • Operating Performance – Strong → Strong → Strong → Strong EBITDA margins improving with CMS mix and process innovation • Dividend Yield (%) – 0.30% → 0.35% → 0.40% → 0.45% Modest payouts; reinvestment-focused strategy • Equity Capital – ₹13.00 Cr (constant) No dilution; lean capital structure • Total Debt – ₹180 Cr → ₹160 Cr → ₹140 Cr → ₹120 Cr Gradual deleveraging supported by internal accruals • Fixed Assets – ₹520 Cr → ₹580 Cr → ₹640 Cr → ₹700 Cr Capex focused on CMS block, peptide scale-up, and regulatory audits Institutional Interest & Ownership Trends Promoter holding stands at 60.04%, with no pledging. FIIs and DIIs have actively accumulated citing CMS visibility and peptide leadership. Delivery volumes reflect long-term positioning by pharma, export, and specialty API-focused funds. Business Growth Verdict Neuland is scaling across CMS, peptide APIs, and global lifecycle partnerships Margins improving due to high-value molecules and backward integration Debt is declining steadily with strong operating cash flows Capex supports long-term competitiveness and audit readiness Management Con Call Highlights • Q1 FY26 revenue rose 22.5% YoY to ₹460 Cr; PAT up 28.2% YoY to ₹52 Cr • Peptide API revenue up 38% YoY; 3 new CMS contracts signed • USFDA audit completed with zero observations; EU audit scheduled • FY26 outlook: 15–18% revenue growth, margin retention, and PAT expected to cross ₹220 Cr Final Investment Verdict Neuland Labs offers a high-conviction specialty pharma story built on CMS depth, peptide scale, and global regulatory credibility. Its improving profitability, disciplined capital structure, and expanding molecule portfolio make it suitable for accumulation by investors seeking exposure to India’s high-end API and contract manufacturing ecosystem. With strong execution, audit readiness, and peptide-led margin expansion, Neuland remains a durable value creator in the global pharma supply chain.
NSE:NEULANDLABLong
by TechnicalAnalystSucrit
NEULAND LAB LTD S/R Support and Resistance Levels: Support Levels: These are price points (green line/shade) where a downward trend may be halted due to a concentration of buying interest. Imagine them as a safety net where buyers step in, preventing further decline. Resistance Levels: Conversely, resistance levels (red line/shade) are where upward trends might stall due to increased selling interest. They act like a ceiling where sellers come in to push prices down. Breakouts: Bullish Breakout: When the price moves above resistance, it often indicates strong buying interest and the potential for a continued uptrend. Traders may view this as a signal to buy or hold. Bearish Breakout: When the price falls below support, it can signal strong selling interest and the potential for a continued downtrend. Traders might see this as a cue to sell or avoid buying. 20 EMA (Exponential Moving Average): Above 20 EMA(50 EMA): If the stock price is above the 20 EMA, it suggests a potential uptrend or bullish momentum. Below 20 EMA: If the stock price is below the 20 EMA, it indicates a potential downtrend or bearish momentum. Trendline: A trendline is a straight line drawn on a chart to represent the general direction of a data point set. Uptrend Line: Drawn by connecting the lows in an upward trend. Indicates that the price is moving higher over time. Acts as a support level, where prices tend to bounce upward. Downtrend Line: Drawn by connecting the highs in a downward trend. Indicates that the price is moving lower over time. It acts as a resistance level, where prices tend to drop. RSI: RSI readings greater than the 70 level are overbought territory, and RSI readings lower than the 30 level are considered oversold territory. Combining RSI with Support and Resistance: Support Level: This is a price level where a stock tends to find buying interest, preventing it from falling further. If RSI is showing an oversold condition (below 30) and the price is near or at a strong support level, it could be a good buy signal. Resistance Level: This is a price level where a stock tends to find selling interest, preventing it from rising further. If RSI is showing an overbought condition (above 70) and the price is near or at a strong resistance level, it could be a signal to sell or short the asset. Disclaimer: I am not a SEBI registered. The information provided here is for learning purposes only and should not be interpreted as financial advice. Consider the broader market context and consult with a qualified financial advisor before making investment decisions.
NSE:NEULANDLAB
by zenthosh
#NEULANDLAB BULLISH SWINGNEULAND LAB on NSE is at a significant pivot point where it has closed above the 50 DEMA, The Stock has had pullback above @ 38.2% of its previous impulse indicating a trend continuation. A CHange of Character(CHoCh) at daily price close above 6450 , this is good entry point with a first target of 7100 (10% gain) to traverse the downward gap of 300 Rs. in the last downward impulse. There has been consistent buying for the past 3 weeks but just below 20Volume MA. Price has closed above 38.2% FIBO. RSI on WEEKLY is at 40 Keep a SL of 6220 the Previous week low, set a Target 1 of 7100 (Gap Close) and Target 2 of 7750 for a (20% gain) the previous Swing High. support at 5900-6100 lvl Can add quantity as per risk appetite above the 61.8% pullback FIBO of 6914.
NSE:NEULANDLABLong
by billpramod